Stories

Thu, 14 May 2026

Thu, 14 May 2026 Biogen advances Alzheimer's drug to late-stage trial despite disappointing data

Biogen said signals suggest the treatment decreases levels of tau and slows cognitive decline, particularly at the lowest dose.


Terms of Use | Privacy Policy | Manage Cookies+ | Ad Choices | Accessibility & CC | About | Newsletters | Transcripts
Business News Top © 2024-2025